Gilead Sciences Inc.

NAS : GILD
Pharmaceuticals
Foster City CA
IW Best50N/A
2012 Revenue (US$ Millions)$9,703
2011 Revenue (US$ Millions)$8,385
Revenue Growth (%)15.71%
Net Income (US$ Millions)$2,592
Common Shares Outstanding (Millions)$1,519
Earnings Per Share (US$)$1.64
Total Equity (US$ Millions)$9,310
Profit Growth (%)-7.56
Profit Margin (%)26.71%
Return On Equity (%)38.46%
Long Term Debt (US$ Millions)$7,283
Debt To Equity Ratio (%)0.78%
Market Capitalization (US$ Millions)$111,583
Total Assets (US$ Millions)$21,240
Return on Assets (%)14.98
Current Assets (US$ Millions)$6,156
Inventories (US$ Millions)$1,745
Current Liabilities (US$ Millions)$4,270
Cost of Goods Sold (US$ Millions)$2,471
Asset Turnover0.46
Inventory Turnover1.58